Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.88
-0.07 (-0.70%)
Nov 20, 2026, 4:00 PM EST - Market closed
Bioventus Revenue
Bioventus had revenue of $142.44M in the quarter ending September 26, 2026, with 2.73% growth. This brings the company's total for the last twelve months to $585.64M, up 3.87% year-over-year. In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%. That makes Bioventus the 10,390th largest company in the world by revenue and 2,199th in the United States.
Revenue (ttm)
$585.64M
Revenue Growth
+3.87%
P/S Ratio
1.42
Revenue / Employee
$610,041
Employees
960
Market Cap
832.50M
Revenue by Segment
- U.S. 502.10M 88.4%
- International 65.99M 11.6%
Fiscal year ended Dec 31, 2025 See the full Bioventus breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 568.09M | -5.19M | -0.91% |
| Dec 31, 2024 | 573.28M | 60.94M | 11.89% |
| Dec 31, 2023 | 512.35M | 228.00K | 0.04% |
| Dec 31, 2022 | 512.12M | 81.22M | 18.85% |
| Dec 31, 2021 | 430.90M | 109.74M | 34.17% |
| Dec 31, 2020 | 321.16M | -18.98M | -5.58% |
| Dec 31, 2019 | 340.14M | 20.96M | 6.57% |
| Dec 31, 2018 | 319.18M | 65.53M | 25.83% |
| Dec 31, 2015 | 253.65M | 10.76M | 4.43% |
| Dec 31, 2014 | 242.89M | 10.52M | 4.53% |
| Dec 31, 2013 | 232.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.44B |
| Integra LifeSciences Holdings | 1.66B |
| Varex Imaging | 865.00M |
| Artivion | 481.88M |
| InMode | 373.60M |
| OrthoPediatrics | 264.14M |
| SI-BONE | 220.65M |
| Cytek Biosciences | 207.65M |
BVS News
- 10 days ago - 3 Small-Cap Healthcare Stocks with More Than 45% Upside, According to Analysts - TipRanks
- 17 days ago - Bioventus price target lowered to $16 from $18 at Craig-Hallum - TheFly
- 17 days ago - Bioventus price target lowered to $16 from $18 at Barrington - TheFly
- 17 days ago - Bioventus price target lowered to $18 from $19 at Canaccord - TheFly
- 18 days ago - Bioventus Earnings Call Transcript: Q3 2026 - Transcripts
- 18 days ago - Bioventus Earnings release: Q3 2026 - Filings
- 18 days ago - Bioventus Quarterly report: Q3 2026 - Filings
- 18 days ago - Bioventus Slides: Q3 2026 - Filings